Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer

被引：0
|
作者：
C Palmieri
M P Caley
K Purshouse
A-V Fonseca
M Rodriguez-Teja
G Kogianni
L Woodley
J Odendaal
K Elliott
J Waxman
J Sturge
机构：
[1] Cancer Research UK Laboratories,Department of Surgery and Cancer
[2] Imperial College London,Department of Medical Oncology
[3] Imperial College Healthcare NHS Trust,Department of Biological Sciences (Biomedical Science)
[4] Charing Cross Hospital,undefined
[5] The Allam Building,undefined
[6] University of Hull,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
bisphosphonates; bone metastasis; breast cancer; collagen receptor; diagnostic marker; plasma marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 169
页数：6
相关论文
共 50 条
  • [31] The Accuracy of Breast Cancer Diagnostic Tools
    Alotaibi, Batool S.
    Alghamdi, Rahaf
    Aljaman, Sadeem
    Hariri, Reem A.
    Althunayyan, Lama S.
    Alsenan, Batool F.
    Alnemer, Areej M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [32] AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival
    Rodriguez-Teja, Mercedes
    Gronau, Julian H.
    Breit, Claudia
    Zhang, Yu Zhi
    Minamidate, Ai
    Caley, Matthew P.
    McCarthy, Afshan
    Cox, Thomas R.
    Erler, Janine T.
    Gaughan, Luke
    Darby, Steven
    Robson, Craig
    Mauri, Francesco
    Waxman, Jonathan
    Sturge, Justin
    JOURNAL OF PATHOLOGY, 2015, 235 (04): : 581 - 592
  • [33] The collagen receptor endo180 (CD280) is expressed on basal-like breast tumor cells and promotes tumor growth in vivo
    Wienke, Dirk
    Davies, Gareth C.
    Johnson, Damian A.
    Sturge, Justin
    Lambros, Maryou B. K.
    Savage, Kay
    Elsheikh, Somaia Elbauomy
    Green, Andrew R.
    Ellis, Ian O.
    Robertson, David
    Reis-Filho, Jorge S.
    Isacke, Clare M.
    CANCER RESEARCH, 2007, 67 (21) : 10230 - 10240
  • [34] Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis
    P. Hadji
    V. Ziller
    J. Kyvernitakis
    N. Schmidt
    K. Kostev
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1149 - 1155
  • [35] Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer
    Winston Liauw
    Eva Segelov
    Anna Lih
    Ms Ruth Dunleavy
    Matthew Links
    Robyn Ward
    BMC Cancer, 5
  • [36] Improving the Use of Intravenous Bisphosphonates in Women With Breast Cancer Metastatic to Bone
    Mortimer, Joanne
    Mendelsohn, Mary
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 : S40 - S42
  • [37] Lack of differences in nephrotoxicity of intravenous bisphosphonates in metastatic breast cancer.
    Luedders, D. W.
    Bohimann, M. K.
    Steinhoff, J.
    Hornemann, A.
    Diedrich, K.
    Thill, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis
    Hadji, P.
    Ziller, V.
    Kyvernitakis, J.
    Schmidt, N.
    Kostev, K.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1149 - 1155
  • [39] Gender differences in persistency to bisphosphonates in patients with metastatic breast and prostate cancer
    Hadji, Peyman
    Kyvernitakis, Jannis
    Albert, Ute
    Jockwig, Joachim
    Kostev, Karel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (05) : 352 - 359
  • [40] Bisphosphonates and reduction of skeletal events in patients with bone metastatic breast cancer
    Rizzoli, R
    ANNALS OF ONCOLOGY, 2004, 15 (05) : 700 - 701
12345